Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Indigofera astragalina extract is a botanical extract derived from the medicinal plant *Indigofera astragalina*, which is traditionally used in Sudanese and Ayurvedic medicine. Preclinical research, including studies by the University of Nottingham, has demonstrated that methanol extracts of the plant (specifically referred to as extract 6) possess selective growth inhibitory and pro-apoptotic activities against human breast cancer cell lines, such as MDA-MB-468. The extract induces cell cycle arrest and apoptosis, as indicated by increased Annexin V staining and cleaved PARP levels. Additionally, the plant extract has been studied for its antioxidant, anti-inflammatory, antimicrobial, and antidiabetic properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on indigofera astragalina extract.